GSH vs Resveratrol: Know Which Line Item Is Which
Not a dismissal — a file description: the headlines priced against the human data, both bets respected, and the buyer told exactly what each purchase is.
At a glance
- The files: GSH = direct human stores trial · resveratrol = pathway hypothesis, mixed translation
- Resveratrol's honest card: mechanism-rich, bioavailability-poor, human-data thin
- Shared truth: zero authorised claims on either — evidence items decide
- The sort: measured strategy vs longevity bet — pick the file you believe
Resveratrol's honest card — the celebrity's file, read fully
Resveratrol arrives with the best origin story in the aisle — the red-wine polyphenol behind the French-paradox headlines, the sirtuin-pathway mechanism literature, the longevity-lab pedigree — and this page reads the whole file rather than the jacket: the cell and animal work is genuinely extensive and generated real scientific excitement; the human translation has run smaller and mixed, with benefits inconsistently replicated across trials; the bioavailability problem is acknowledged by the field itself — standard oral resveratrol is rapidly metabolised, prompting ongoing debates about doses, forms and whether meaningful exposure is even achieved; and the regulatory position matches glutathione's exactly: zero authorised UK claims at any dose. None of that is dismissal — molecules deserve their research programmes — but a shelf price should match a file, and resveratrol's typically premium tickets are priced like the headlines, not the human data (the same three-layer sort, applied fairly to a rival).
The comparison — measured strategy versus hypothesis bet
The honest axis between two claim-free molecules is evidence type: glutathione's file centres on a direct human finding — the six-month trial measuring body stores rising on daily oral GSH (its absorption context): narrow, unglamorous, measured; resveratrol's centres on a pathway hypothesis — compelling mechanism, aspirational endpoint (healthy ageing), thin confirmed human translation: broad, glamorous, unproven. Buying either is legitimate; confusing them is the error this page prevents: the GSH buyer purchases a measurable repletion strategy with quiet expected (the clock); the resveratrol buyer purchases a longevity bet whose payoff, if any, is unverifiable at the individual level by design — and the biohacker running both should at least know which line item is which (the stacks page's fuller map, the NMN sibling comparison).
Futuro Labs Glutathione
£22.99 for 30-day supply · 77p per day
Pros
- 500mg reduced glutathione (GSH) per serving — the active form
- UK manufactured under GMP certification
- Single-ingredient, vegan, no fillers
- Independently lab tested — microbiology and heavy metals
- ~77p per day vs £1.20-1.80/day for liposomal formats
Cons
- Capsule format — no liposomal delivery system
- Newer brand versus heritage names like Solgar
Available from: Amazon UK — £22.99
The router — and both bets priced honestly
Sorted by buyer: the evidence-first strategist — glutathione's direct trial is the closest thing this comparison offers to a measured purchase, and Futuro Labs Glutathione runs it at the honest floor: 500mg reduced glutathione daily, single-ingredient vegan, independent testing shown, £22.99/30 days at ~77p (the record); the longevity-hypothesis buyer — resveratrol taken knowingly as a bet (mechanism believed, translation gap owned, bioavailability caveat priced) is a defensible speculative position this page respects without joining; the both reader — no interaction concern at label doses, but two bets stacked by default is budget theatre: stagger starts, own each rationale, review each line at 12 weeks separately (the review). Constants for every basket: the production inputs that outrank both bottles (the hierarchy), zero felt effects promised anywhere on this page, and the gates — pregnancy/breastfeeding → medical advice; prescription medication → pharmacist minute (the routing). The celebrity and the hub, filed honestly: one sells a story still being tested, one sells a measurement already made — price accordingly.
Frequently asked questions
Glutathione or resveratrol — which is better?
Two claim-free molecules with very different files: resveratrol is the red-wine-derived longevity celebrity — a large mechanism literature (sirtuin pathways), famously mixed human translation, and bioavailability problems its own researchers acknowledge; glutathione is the endogenous hub with a direct human stores trial. Neither holds authorised UK claims; the honest sort is measured-repletion strategy versus longevity-hypothesis bet.
Does resveratrol actually work in humans?
The honest status: cell and animal work generated enormous excitement, human trials have been smaller and mixed, standard oral resveratrol is poorly bioavailable (rapidly metabolised), and the field itself debates dosing and forms. That's not a dismissal — it's a file description: hypothesis-rich, translation-thin, and priced like neither.
Can you take both?
No interaction concern at label doses — but the honest framing is two separate bets: one on a measured repletion endpoint (GSH's trial), one on a longevity hypothesis (resveratrol's pathway story). Budget and attribution both favour picking the file you actually believe in over stacking both by default.